ICPT Intercept Pharmaceuticals Inc

Intercept Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel therapeutics to treat non-viral, progressive liver diseases with high unmet medical need.

$14.02  -0.07 (-0.50%)
As of 10/05/2022 15:59:56 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/11/2012
Outstanding shares:  29,798,040
Average volume:  1,466,403
Market cap:   $401,677,579
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B7N59F8
Valuation   (See tab for details)
PE ratio:   -6.15
PB ratio:   8.98
PS ratio:   1.08
Return on equity:   18.37%
Net income %:   -18.44%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy